[1] KAGAMI S, RIZZO H L, LEE J J, et al.Cell are increased in psoriasis［J］.J Invest Dermatol, 2010, 130(5): 1373-1383.

[2] 朱菁, 聂凡, 袁霞雯, 等.细胞因子与银屑病的相关性及ILLLI对其变化的影响［J］.应用激光, 2001, 21(5): 337-343.

[3] 聂凡, 张慧国, 袁霞雯, 等.ILLLI对银屑病患者外周血CD4+T细胞Fas蛋白表达的影响［J］.应用激光, 2002, 22(3): 345-348.

[4] 朱菁, 聂凡, 施虹敏, 等.低能量激光血管内照射治疗银屑病［J］.应用激光, 2001, 21(4): 265-267.

[5] 李薇, 王立新, 刘颖, 等.0.03%他克莫斯软膏联合308 nm准分子激光治疗斑块状银屑病临床观察［J］.中国皮肤性病学杂质, 2012, 26(12): 1152-1154.

[6] 徐雁, 刘俊, 张怡, 等.308 nm准分子激光联合卡泊三醇软膏治疗斑块状银屑病疗效评价［J］.中国麻风皮肤病杂质, 2014, 30(2): 85-86.

[7] SCHIMITT J, WOZEL G.The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis［J］.Dermatology, 2005, 210(3): 194-199.

[8] QUAGLINO P, BERGALLO M, PONTI R, et al.Thl,Th2,Thl7 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response［J］.Dermatology, 2011, 223(1): 57-67.

[9] NAKAJIMA K.Critical role of the interleukin-23/T-helped7 cell axis in the pathogenesis of psoriasis［J］.J Dermatol, 2012, 39(3): 219-224.

[10] SUGIYAMA H, GYULAI R, TOICHI E, el a1.Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effectors T cell proliferation［J］.J Immunol, 2005, 174(1): 164-173.

[11] KAGEN M H, ME-CORMICK T S, COOPER K D.Regulatory T cells in psoriasis［J］.Ernst Sehering Res Found Workshop, 2006(56): 193-209.

[12] GOODMAN W A, LEVINE A D, MASSARI J V, et al.IL-6 signaling in psoriasis orevents immune suppression by regulatory T cells［J］.J Immunol, 2009, 183(5): 3170-3176.